| Saponins in cancer treatment: Current progress and future prospects OO Elekofehinti, O Iwaloye, F Olawale, EO Ariyo Pathophysiology 28 (2), 250-272, 2021 | 116 | 2021 |
| Molecular docking studies, molecular dynamics and ADME/tox reveal therapeutic potentials of STOCK1N-69160 against papain-like protease of SARS-CoV-2 OO Elekofehinti, O Iwaloye, SS Josiah, AO Lawal, MO Akinjiyan, EO Ariyo Molecular Diversity 25, 1761-1773, 2021 | 64 | 2021 |
| In silico molecular studies of natural compounds as possible anti-Alzheimer’s agents: ligand-based design O Iwaloye, OO Elekofehinti, AI Momoh, K Babatomiwa, EO Ariyo Network Modeling Analysis in Health Informatics and Bioinformatics 9, 1-14, 2020 | 51 | 2020 |
| Therapeutic potential of Chromolaena odorata phyto-constituents against human pancreatic α-amylase B Kikiowo, JA Ogunleye, O Iwaloye, TT Ijatuyi Journal of Biomolecular Structure and Dynamics 40 (4), 1801-1812, 2022 | 47 | 2022 |
| Computational study of the therapeutic potentials of a new series of imidazole derivatives against SARS-CoV-2 TO Johnson, AE Adegboyega, O Iwaloye, OA Eseola, W Plass, B Afolabi, ... Journal of pharmacological sciences 147 (1), 62-71, 2021 | 47 | 2021 |
| Insight into glycogen synthase kinase-3β inhibitory activity of phyto-constituents from Melissa officinalis: in silico studies O Iwaloye, OO Elekofehinti, EA Oluwarotimi, B Kikiowo, TM Fadipe In silico pharmacology 8, 1-13, 2020 | 47 | 2020 |
| A Computational Approach to Elucidate the Interactions of Chemicals From Artemisia annua Targeted Toward SARS-CoV-2 Main Protease Inhibition for COVID-19 … TO Johnson, AE Adegboyega, OA Ojo, AJ Yusuf, O Iwaloye, ... Frontiers in medicine 9, 907583, 2022 | 45 | 2022 |
| Biological activities of Chromolaena odorata: A mechanistic review F Olawale, K Olofinsan, O Iwaloye South African Journal of Botany 144, 44-57, 2022 | 43 | 2022 |
| Discovery of potential visfatin activators using in silico docking and ADME predictions as therapy for type 2 diabetes OO Elekofehinti, OC Ejelonu, JP Kamdem, OB Akinlosotu, A Famuti, ... Beni-Suef University Journal of Basic and Applied Sciences 7 (2), 241-249, 2018 | 42 | 2018 |
| Molecular dynamics simulation and pharmacokinetics studies of ombuin and quercetin against human pancreatic α-amylase B Kikiowo, I Ahmad, AA Alade, T T. Ijatuyi, O Iwaloye, HM Patel Journal of Biomolecular Structure and Dynamics 41 (20), 10388-10395, 2023 | 34 | 2023 |
| Momordica charantia silver nanoparticles modulate SOCS/JAK/STAT and P13K/Akt/PTEN signalling pathways in the kidney of streptozotocin-induced diabetic rats OO Elekofehinti, VO Oyedokun, O Iwaloye, AO Lawal, OC Ejelonu Journal of Diabetes & Metabolic Disorders 20, 245-260, 2021 | 32 | 2021 |
| Polypharmacology of Gongronema latifolium leaf secondary metabolites against protein kinases implicated in Parkinson's disease and Alzheimer's disease BE Oyinloye, O Iwaloye, BO Ajiboye Scientific African 12, e00826, 2021 | 31 | 2021 |
| Discovery of traditional Chinese medicine derived compounds as wild type and mutant Plasmodium falciparum dihydrofolate reductase inhibitors: induced fit docking and ADME studies O Iwaloye, OO Elekofehinti, B Kikiowo, TM Fadipe, MO Akinjiyan, ... Current drug discovery technologies 18 (4), 554-569, 2021 | 29 | 2021 |
| Identification of main protease of coronavirus SARS-CoV-2 (Mpro) Inhibitors from Melissa officinalis OO Elekofehinti, O Iwaloye, CD Famusiwa, O Akinseye, JBT Rocha Current drug discovery technologies 18 (5), 38-52, 2021 | 26 | 2021 |
| Phytochemicals from Nigerian medicinal plants modulate therapeutically-relevant diabetes targets: insight from computational direction F Olawale, K Olofinsan, O Iwaloye, TE Ologuntere Advances in Traditional Medicine, 1-15, 2021 | 25 | 2021 |
| Computer-aided drug design in anti-cancer drug discovery: What have we learnt and what is the way forward? O Iwaloye, PO Ottu, F Olawale, OO Babalola, OO Elekofehinti, B Kikiowo, ... Informatics in Medicine Unlocked 41, 101332, 2023 | 24 | 2023 |
| Virtual screening of natural compounds as selective inhibitors of polo-like kinase-1 at C-terminal polo box and N-terminal catalytic domain F Olawale, O Iwaloye, OO Elekofehinti Journal of Biomolecular Structure and Dynamics 40 (24), 13606-13624, 2022 | 23 | 2022 |
| Identification of lead compounds from large natural product library targeting 3C-like protease of SARS-CoV-2 using E-pharmacophore modelling, QSAR and molecular dynamics simulation OO Elekofehinti, O Iwaloye, OR Molehin, CD Famusiwa In Silico Pharmacology 9 (1), 49, 2021 | 19 | 2021 |
| Predictive hybrid paradigm for cytotoxic activity of 1, 3, 4-thiadiazole derivatives as CDK6 inhibitors against human (MCF-7) breast cancer cell line and its structural … PO Chukwuemeka, HI Umar, O Iwaloye, OM Oretade, CB Olowosoke, ... Journal of Biomolecular Structure and Dynamics 40 (18), 8518-8537, 2022 | 18 | 2022 |
| In silico molecular studies of selected compounds as novel inhibitors for phosphodiesterase-5 (PDE5) in the management of erectile dysfunction O Iwaloye, OO Elekofehinti, K Babatomiwa, TM Fadipe J Comput Sci Syst Biol 13 (307), 2, 2020 | 16 | 2020 |
Olusola ElekofehintiAdekunle Ajasin University, Akungba Akoko, Ondo State. Nigeria在 aaua.edu.ng 的电子邮件经过验证
